Article (Scientific journals)
Prescription and efficacy of daclatasvir and sofosbuvir +/- ribavirin for hepatitis C infection, including patient-reported outcomes, in routine practice in three European countries: the CMPASS-EU cohort study.
Bourgeois, Stefan; Van Erpecum, Karel; DELWAIDE, Jean et al.
2020In Cogent Medicine, 7 (1), p. 1727169
Peer Reviewed verified by ORBi
 

Files


Full Text
CMPASS 2020.pdf
Publisher postprint (1.19 MB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
Gastroenterology & hepatology
Author, co-author :
Bourgeois, Stefan
Van Erpecum, Karel
DELWAIDE, Jean ;  Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de gastroentérologie, hépatologie, onco. digestive
Naumann, Uwe
Christensen, Stefan
Moreno, Christophe
Pathil, Anita
Schippers, Emile
Van Emmerik, Nancy
Caritey, Benoit
Fischer, Conrad
Mercier, Florence
Petersenon, Joerg
More authors (3 more) Less
Language :
English
Title :
Prescription and efficacy of daclatasvir and sofosbuvir +/- ribavirin for hepatitis C infection, including patient-reported outcomes, in routine practice in three European countries: the CMPASS-EU cohort study.
Publication date :
2020
Journal title :
Cogent Medicine
eISSN :
2331-205X
Publisher :
Taylor & Francis Group, United Kingdom
Volume :
7
Issue :
1
Pages :
1727169
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 22 February 2020

Statistics


Number of views
57 (4 by ULiège)
Number of downloads
68 (4 by ULiège)

OpenCitations
 
1

Bibliography


Similar publications



Contact ORBi